Granules India Limited (GRANULES.BO)
INR 452.1
(4.85%)
INR 452.1
(4.85%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 45.06 Billion INR | 0.22% |
| 2022 | 44.96 Billion INR | 20.64% |
| 2021 | 37.27 Billion INR | 16.62% |
| 2020 | 31.96 Billion INR | 25.57% |
| 2019 | 25.45 Billion INR | 13.91% |
| 2018 | 22.34 Billion INR | 36.7% |
| 2017 | 16.34 Billion INR | 15.95% |
| 2016 | 14.09 Billion INR | 3.99% |
| 2015 | 13.55 Billion INR | 4.84% |
| 2014 | 12.92 Billion INR | 17.98% |
| 2013 | 10.95 Billion INR | 43.37% |
| 2012 | 7.64 Billion INR | 16.88% |
| 2011 | 6.53 Billion INR | 37.62% |
| 2010 | 4.75 Billion INR | 3.06% |
| 2009 | 4.61 Billion INR | 0.0% |
| 2008 | - INR | -100.0% |
| 2007 | 2.56 Billion INR | 36.31% |
| 2006 | 1.88 Billion INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 11.79 Billion INR | 0.35% |
| 2023 Q4 | 11.75 Billion INR | 1.75% |
| 2023 Q3 | 11.55 Billion INR | -2.85% |
| 2023 FY | 45.06 Billion INR | 0.22% |
| 2023 Q1 | 9.85 Billion INR | -16.48% |
| 2023 Q2 | 11.89 Billion INR | 20.7% |
| 2022 Q4 | 11.79 Billion INR | 2.95% |
| 2022 Q3 | 11.46 Billion INR | -0.4% |
| 2022 FY | 44.96 Billion INR | 20.64% |
| 2022 Q1 | 10.19 Billion INR | 2.75% |
| 2022 Q2 | 11.5 Billion INR | 12.87% |
| 2021 Q4 | 9.92 Billion INR | -0.46% |
| 2021 Q1 | 8.49 Billion INR | 12.15% |
| 2021 FY | 37.27 Billion INR | 16.62% |
| 2021 Q3 | 9.96 Billion INR | 12.21% |
| 2021 Q2 | 8.88 Billion INR | 4.53% |
| 2020 Q1 | 7.35 Billion INR | 34.61% |
| 2020 Q2 | 8.58 Billion INR | 16.66% |
| 2020 Q4 | 7.57 Billion INR | -10.27% |
| 2020 FY | 31.96 Billion INR | 25.57% |
| 2020 Q3 | 8.44 Billion INR | -1.59% |
| 2019 Q4 | 5.46 Billion INR | -22.37% |
| 2019 Q1 | 5.95 Billion INR | 4.71% |
| 2019 Q3 | 7.03 Billion INR | 0.63% |
| 2019 Q2 | 6.99 Billion INR | 17.51% |
| 2019 FY | 25.45 Billion INR | 13.91% |
| 2018 Q3 | 6.31 Billion INR | 8.76% |
| 2018 FY | 22.34 Billion INR | 36.7% |
| 2018 Q1 | 4.53 Billion INR | -10.04% |
| 2018 Q2 | 5.8 Billion INR | 28.16% |
| 2018 Q4 | 5.68 Billion INR | -10.02% |
| 2017 Q1 | 3.77 Billion INR | 6.27% |
| 2017 FY | 16.34 Billion INR | 15.95% |
| 2017 Q4 | 5.03 Billion INR | 22.66% |
| 2017 Q3 | 4.1 Billion INR | 4.63% |
| 2017 Q2 | 3.92 Billion INR | 3.99% |
| 2016 FY | 14.09 Billion INR | 3.99% |
| 2016 Q4 | 3.55 Billion INR | 0.59% |
| 2016 Q3 | 3.53 Billion INR | -1.46% |
| 2016 Q2 | 3.58 Billion INR | 4.27% |
| 2016 Q1 | 3.43 Billion INR | -8.53% |
| 2015 FY | 13.55 Billion INR | 4.84% |
| 2015 Q4 | 3.75 Billion INR | 15.73% |
| 2015 Q2 | 3.52 Billion INR | 9.41% |
| 2015 Q1 | 3.22 Billion INR | -9.09% |
| 2015 Q3 | 3.24 Billion INR | -7.93% |
| 2014 Q4 | 3.54 Billion INR | 10.93% |
| 2014 Q3 | 3.19 Billion INR | 3.91% |
| 2014 Q2 | 3.07 Billion INR | -1.09% |
| 2014 FY | 12.92 Billion INR | 17.98% |
| 2014 Q1 | 3.11 Billion INR | -2.03% |
| 2013 Q3 | 2.84 Billion INR | 6.77% |
| 2013 Q4 | 3.17 Billion INR | 11.77% |
| 2013 Q2 | 2.66 Billion INR | 16.54% |
| 2013 Q1 | 2.28 Billion INR | 11.7% |
| 2013 FY | 10.95 Billion INR | 43.37% |
| 2012 Q3 | 1.95 Billion INR | 11.24% |
| 2012 Q4 | 2.04 Billion INR | 4.69% |
| 2012 FY | 7.64 Billion INR | 16.88% |
| 2012 Q1 | 1.89 Billion INR | 0.0% |
| 2012 Q2 | 1.75 Billion INR | -7.28% |
| 2011 FY | 6.53 Billion INR | 37.62% |
| 2010 FY | 4.75 Billion INR | 3.06% |
| 2009 FY | 4.61 Billion INR | 0.0% |
| 2008 FY | - INR | -100.0% |
| 2007 FY | 2.56 Billion INR | 36.31% |
| 2006 FY | 1.88 Billion INR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Sun Pharmaceutical Industries Limited | 484.96 Billion INR | 90.708% |
| NATCO Pharma Limited | 40.02 Billion INR | -12.603% |
| Suven Pharmaceuticals Limited | 10.51 Billion INR | -328.625% |
| Syncom Formulations (India) Limited | 2.59 Billion INR | -1638.272% |
| Achyut Healthcare Limited | 61.36 Million INR | -73330.673% |
| Ajanta Pharma Limited | 42.08 Billion INR | -7.072% |
| Alkem Laboratories Limited | 126.67 Billion INR | 64.426% |
| Alpa Laboratories Limited | 1.08 Billion INR | -4044.205% |
| Alembic Pharmaceuticals Limited | 61.12 Billion INR | 26.272% |
| AstraZeneca Pharma India Limited | 12.95 Billion INR | -247.84% |
| Aurobindo Pharma Limited | 287.04 Billion INR | 84.301% |
| Bajaj HealthCare Limited | 4.73 Billion INR | -851.879% |
| Bliss GVS Pharma Limited | 7.7 Billion INR | -485.056% |
| Brooks Laboratories Limited | 794.86 Million INR | -5569.377% |
| Divi's Laboratories Limited | 78.45 Billion INR | 42.557% |
| Dr. Reddy's Laboratories Limited | 279.16 Billion INR | 83.858% |
| Eris Lifesciences Limited | 20.09 Billion INR | -124.293% |
| FDC Limited | 19.42 Billion INR | -131.935% |
| Glenmark Pharmaceuticals Limited | 118.13 Billion INR | 61.853% |
| Glenmark Life Sciences Limited | 22.83 Billion INR | -97.369% |
| Gufic Biosciences Limited | 8.06 Billion INR | -458.641% |
| Hester Biosciences Limited | 3.04 Billion INR | -1379.7% |
| Indoco Remedies Limited | 17.89 Billion INR | -151.83% |
| Ind-Swift Laboratories Limited | 12.8 Billion INR | -251.813% |
| Ipca Laboratories Limited | 76.22 Billion INR | 40.88% |
| Jagsonpal Pharmaceuticals Limited | 2.08 Billion INR | -2059.235% |
| Krebs Biochemicals & Industries Limited | 504.21 Million INR | -8837.392% |
| Lasa Supergenerics Limited | 1.04 Billion INR | -4219.133% |
| Laurus Labs Limited | 50.01 Billion INR | 9.905% |
| Lupin Limited | 200.1 Billion INR | 77.48% |
| Mankind Pharma Limited | 103.34 Billion INR | 56.396% |
| Medicamen Biotech Limited | 1.79 Billion INR | -2413.224% |
| Medico Remedies Limited | 1.44 Billion INR | -3009.54% |
| Megasoft Limited | 373.95 Million INR | -11950.624% |
| Piramal Pharma Limited | 81.71 Billion INR | 44.85% |
| RPG Life Sciences Limited | 5.82 Billion INR | -674.223% |
| Sigachi Industries Limited | 3.98 Billion INR | -1029.54% |
| Sun Pharma Advanced Research Company Limited | 755.45 Million INR | -5865.119% |
| Unichem Laboratories Limited | 16.57 Billion INR | -171.891% |
| Wanbury Limited | 5.75 Billion INR | -682.831% |
| Windlas Biotech Limited | 6.3 Billion INR | -614.213% |
| ZIM Laboratories Limited | 3.67 Billion INR | -1126.475% |
| Zydus Lifesciences Limited | 190.21 Billion INR | 76.309% |
| Procter & Gamble Health Limited | 11.51 Billion INR | -291.429% |
| Amrutanjan Health Care Limited | 4.21 Billion INR | -969.81% |
| Bal Pharma Limited | 3.39 Billion INR | -1228.451% |
| Strides Pharma Science Limited | 40.51 Billion INR | -11.237% |
| Venus Remedies Limited | 5.91 Billion INR | -661.919% |
| Aarti Pharmalabs Limited | 18.15 Billion INR | -148.216% |
| Nectar Lifesciences Limited | 16.84 Billion INR | -167.585% |
| Shilpa Medicare Limited | 11.51 Billion INR | -291.313% |
| Aarti Drugs Limited | 25.28 Billion INR | -78.218% |
| IOL Chemicals and Pharmaceuticals Limited | 21.18 Billion INR | -112.669% |
| Suven Life Sciences Limited | 116.92 Million INR | -38439.344% |
| Ind-Swift Limited | 5.02 Billion INR | -796.846% |
| Valiant Laboratories Limited | 1.82 Billion INR | -2375.248% |
| J. B. Chemicals & Pharmaceuticals Limited | 34.84 Billion INR | -29.338% |
| Solara Active Pharma Sciences Limited | 12.38 Billion INR | -263.889% |
| Themis Medicare Limited | 3.81 Billion INR | -1080.416% |
| Hikal Limited | 17.84 Billion INR | -152.514% |
| Torrent Pharmaceuticals Limited | 106.05 Billion INR | 57.509% |
| Sequent Scientific Limited | 13.69 Billion INR | -228.996% |
| Novartis India Limited | 3.35 Billion INR | -1244.903% |
| Wockhardt Limited | 27.89 Billion INR | -61.576% |
| Jubilant Pharmova Limited | 67.02 Billion INR | 32.77% |
| Biofil Chemicals and Pharmaceuticals Limited | 400.35 Million INR | -11155.984% |
| Neuland Laboratories Limited | 15.58 Billion INR | -189.133% |
| Morepen Laboratories Limited | 17.01 Billion INR | -164.785% |
| Kilitch Drugs (India) Limited | 1.54 Billion INR | -2819.151% |
| Mangalam Drugs & Organics Limited | 3.68 Billion INR | -1122.58% |